Michael Aaron Leabman Sells 3,293 Shares of Movano (NASDAQ:MOVE) Stock

Movano Inc. (NASDAQ:MOVE) CTO Michael Aaron Leabman sold 3,293 shares of the business’s stock in a transaction on Wednesday, January 7th. The stock was sold at an average price of $7.34, for a total transaction of $24,170.62. Following the transaction, the chief technology officer owned 39,313 shares of the company’s stock, valued at approximately $288,557.42. The trade was a 7.73% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Michael Aaron Leabman also recently made the following trade(s):

• On Friday, January 9th, Michael Aaron Leabman sold 783 shares of Movano stock. The shares were sold at an average price of $7.27, for a total value of $5,692.41.
• On Thursday, January 8th, Michael Aaron Leabman sold 3,593 shares of Movano stock. The stock was sold at an average price of $7.26, for a total value of $26,085.18.

Movano Stock Performance

NASDAQ:MOVE opened at $7.05 on Wednesday. Movano Inc. has a 1 year low of $4.67 and a 1 year high of $58.76. The stock has a market cap of $5.85 million, a P/E ratio of -0.65 and a beta of 0.79. The stock has a 50-day simple moving average of $8.86 and a 200-day simple moving average of $7.57.

Movano (NASDAQ:MOVE) last posted its earnings results on Friday, November 14th. The technology company reported ($4.73) earnings per share for the quarter, topping the consensus estimate of ($7.00) by $2.27. The firm had revenue of $0.08 million during the quarter, compared to analysts’ expectations of $3.88 million. Movano had a negative return on equity of 647.91% and a negative net margin of 3,409.60%.

Wall Street Analysts Forecast Growth

MOVE has been the topic of several research analyst reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of Movano in a research note on Wednesday, October 8th. Wall Street Zen upgraded Movano to a “hold” rating in a research report on Saturday, December 20th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Movano has a consensus rating of “Sell”.

Institutional Investors Weigh In On Movano

A hedge fund recently bought a new stake in Movano stock. Citadel Advisors LLC purchased a new stake in Movano Inc. (NASDAQ:MOVE) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned 5.94% of Movano as of its most recent SEC filing. Institutional investors own 16.64% of the company’s stock.

Key Headlines Impacting Movano

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Institutional buying: Citadel Advisors reported a new stake (~49,262 shares, ~5.94% of the company) in Movano, which can provide demand/support for the stock and signal outside interest from a large quant manager. MarketBeat: Movano institutional holdings
• Neutral Sentiment: Short-interest picture improving but data glitched: reported short interest fell to 43,438 shares as of Dec. 31 (~5.8% of float, 0.5 days to cover), which reduces near‑term short‑squeeze risk. However a Jan. 12 report showing 0 shares appears to be a reporting error — treat January short‑interest prints cautiously. (No direct company action.)
• Negative Sentiment: Insider selling — CFO Jeremy Cogan disclosed sales: 1,879 shares (Jan. 5 at $8.35) and 8,218 shares (Jan. 6 at $7.79), materially trimming his stake. Insider sales at current low liquidity can be interpreted negatively by the market. SEC filing: Jeremy Cogan insider sales
• Negative Sentiment: More insider selling — CTO Michael Aaron Leabman sold multiple tranches (Jan. 7–9) totaling several thousand shares at ~ $7.26–$7.34, trimming his holdings. Multiple insider sales in close succession weigh on sentiment for a micro‑cap with low free float. SEC filing: Michael Aaron Leabman insider sales
• Negative Sentiment: Weak near‑term fundamentals: latest quarterly results (Nov. 14) showed a large EPS loss but a modest beat; revenue was essentially negligible (~$0.08M vs. est. ~$3.9M). Low revenue and deep negative margins increase execution and dilution risk, which matters more for a very small market‑cap company. MarketBeat: Movano earnings summary

About Movano

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.